GCP
TDOC icon

Garelick Capital Partners’s Teladoc Health TDOC Stock Holding History

Garelick Capital Partners’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-188,352
Closed -$10.9M – 37
2018
Q2 		$10.9M Buy
+188,352
New +$9.2M 2.24% 21

Other funds holding TDOC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Garelick Capital Partners's TDOC Position: Q3 2018 in Review

Garelick Capital Partners sold out of Teladoc Health (TDOC) in Q3 2018, closing a stake of 188,352 shares — an estimated $10.9M sold.

Garelick Capital Partners first reported a position in TDOC in Q2 2018 and held it in 1 quarter. The position peaked at $10.9M in Q2 2018. 334 funds tracked by Wall St. Rank hold TDOC as of Q3 2018.

  • Garelick Capital Partners reported no remaining Teladoc Health position as of Q3 2018 after selling out during the quarter.
  • Garelick Capital Partners sold 188,352 Teladoc Health shares in Q3 2018, an estimated $10.9M.
  • Garelick Capital Partners first reported a position in Teladoc Health in Q2 2018 and held it in 1 quarter.
  • Garelick Capital Partners's Teladoc Health position peaked at $10.9M in Q2 2018.
  • 334 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2018.

Based on Garelick Capital Partners's 13F filing for Q3 2018, filed 14 Nov 2018.